Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice
- 1 October 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 58 (4) , 566-572
Abstract
Guidelines recommend a combination of 2 drugs to be used as first-step treatment strategy in high-risk hypertensive individuals to achieve timely blood pressure control and avoid early events. The evidence that this is associated with cardiovascular (CV) benefits compared with initial monotherapy is limited, however. The objective of this study was to assess whether, compared with antihypertensive monotherapy, a combination of antihypertensive drugs provides a greater CV protection in daily clinical practice. A population-based, nested case-control study was carried out by including the cohort of 209 650 patients from Lombardy (Italy) aged 40 to 79 years who were newly treated with antihypertensive drugs between 2000 and 2001. Cases were the 10 688 patients who experienced a hospitalization for CV disease from initial prescription until 2007. Three controls were randomly selected for each case. Logistic regression was used to model the CV risk associated with starting on and/or continuing with combination therapy. A Monte-Carlo sensitivity analysis was performed to account for unmeasured confounders. Patients starting on combination therapy had an 11% CV risk reduction with respect to those starting on monotherapy (95% CI: 5% to 16%). Compared with patients who maintained monotherapy also during follow-up, those who started on combination therapy and kept it along the entire period of observation had 26% reduction of CV risk (95% CI: 15% to 35%). In daily life practice, a combination of antihypertensive drugs is associated with a great reduction of CV risk. The indication for using combination of blood pressure drugs should be broadened.Keywords
This publication has 26 references indexed in Scilit:
- Blood pressure control by the nifedipine GITS–telmisartan combination in patients at high cardiovascular risk: the TALENT studyJournal Of Hypertension, 2011
- Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practiceJournal Of Hypertension, 2010
- The Clock Is Ticking: The Case for Achieving More Rapid Control of HypertensionThe Journal of Clinical Hypertension, 2010
- Effect of Intensive Versus Standard Blood Pressure Lowering on Diastolic Function in Patients With Uncontrolled Hypertension and Diastolic DysfunctionHypertension, 2010
- Do socioeconomic disparities affect accessing and keeping antihypertensive drug therapy? Evidence from an Italian population-based studyJournal of Human Hypertension, 2008
- The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and strokeCurrent Medical Research and Opinion, 2007
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapyJournal of Human Hypertension, 2006
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureHypertension, 2003
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992